No Data Available
Albert David Share Price
Open | 826.95 |
High | 842.25 |
Low | 810.10 |
Prev Close | 824.00 |
Volume | 3,763 |
VWAP(₹) | 827.59 |
Albert David share price insights
New 52 Week Low
Stock touched a new 52 week low today.Contingent Liabilities Coverage
Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)PAT: Slipping to Red
Company has posted a loss of Rs 9.39 cr in Dec 31, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 57.72% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)Albert David Share Price Update
Albert David Ltd. share price moved up by 1.33% from its previous close of Rs 824.00. Albert David Ltd. stock last traded price is 834.90
Share Price Value Today/Current/Last 834.90 Previous Day 824.00
Found Insights useful?
Albert David Share Price Returns
1 Day | 1.33% |
1 Month | -28.22% |
3 Months | -39.26% |
1 Year | -34.23% |
3 Years | 59.8% |
5 Years | 98.57% |
Key Metrics
PE Ratio(x) | 11.78 |
EPS - TTM(₹) | 70.86 |
MCap(₹ Cr.) | 476.29 |
MCap Rank | 85 |
PB Ratio(x) | 1.23 |
Div Yield(%) | 1.38 |
Face Value(₹) | 10.00 |
52W High(₹) | 1,753.95 |
52W Low(₹) | 810.10 |
MCap/Sales | 1.69 |
Beta(1 Month) | 0.81 |
BV/Share(₹) | 671.05 |
Albert David Share Recommendations
- Target₹570
- OrganizationIndependent Analyst
- BUY
Albert David News & Analysis
Albert David Financials
Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Total Income 74.08 119.07 112.42 99.50 105.16 Total Income Growth (%) -37.79 5.92 12.98 -5.39 -0.10 Total Expenses 84.11 93.88 90.26 81.32 81.61 Total Expenses Growth (%) -10.41 4.01 11.00 -0.36 3.74 EBIT -10.03 25.19 22.16 18.18 23.55 EBIT Growth (%) -139.82 13.71 21.85 -22.81 -11.46 Profit after Tax (PAT) -9.39 18.07 18.84 12.91 18.72 PAT Growth (%) -151.95 -4.10 45.94 -31.01 -7.79 EBIT Margin (%) -13.54 21.16 19.71 18.27 22.40 Net Profit Margin (%) -12.67 15.18 16.76 12.98 17.80 Basic EPS (₹) -16.45 31.67 33.02 22.63 32.80 All figures in Rs Cr, unless mentioned otherwise
InsightsPAT: Slipping to Red
Company has posted a loss of Rs 9.39 cr in Dec 31, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)Quarterly Topline Performance
Company witnessed QoQ revenue decline of 37.79%, which is lowest in the last 3 years. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 497.99 423.39 402.84 341.40 320.22 Total Assets Growth (%) 17.62 5.10 18.00 6.61 8.41 Total Liabilities 115.01 111.82 123.37 97.02 97.42 Total Liabilities Growth (%) 2.85 -9.36 27.16 -0.41 14.69 Total Equity 382.98 311.57 279.47 244.38 222.80 Total Equity Growth (%) 22.92 11.49 14.36 9.69 5.87 Current Ratio (x) 3.75 3.07 2.33 2.77 2.48 Total Debt to Equity (x) 0.01 0.01 0.01 0.00 0.01 Contingent Liabilities 5.27 8.23 2.81 4.07 4.14 All figures in Rs Cr, unless mentioned otherwise
InsightsContingent Liabilities Coverage
Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 45.50 10.52 40.36 36.61 30.09 Net Cash used in Investing Activities -33.25 -5.00 -39.70 -36.68 -20.00 Net Cash flow from Financing Activities -8.27 -6.36 -4.88 -1.71 -10.17 Net Cash Flow 3.99 -0.83 -4.13 -1.77 0.00 Closing Cash & Cash Equivalent 5.44 1.45 -1.49 4.64 6.42 Closing Cash & Cash Equivalent Growth (%) 276.29 -197.04 -132.08 -27.65 0.07 Total Debt/ CFO (x) 0.05 0.38 0.09 0.01 0.05 All figures in Rs Cr, unless mentioned otherwise
InsightsCash from Operations vs PAT
Operating cash flow of Rs 45.5 cr is 0.6 times compared to the reported net profit of Rs 75.42 cr. (Source: Standalone Financials)Increase in Cash from Investing
Company has used Rs 33.25 cr for investing activities which is an YoY increase of 565.6%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 19.69 11.61 12.61 9.06 8.60 Return on Capital Employed (%) 24.46 15.77 16.27 10.77 12.43 Return on Assets (%) 15.14 8.54 8.75 6.48 5.98 Interest Coverage Ratio (x) 325.13 131.04 106.40 55.62 37.37 Asset Turnover Ratio (x) 0.79 0.83 0.84 0.75 100.18 Price to Earnings (x) 8.14 8.08 8.61 9.72 9.59 Price to Book (x) 1.60 0.94 1.09 0.88 0.82 EV/EBITDA (x) 5.60 4.53 5.10 4.96 4.76 EBITDA Margin (%) 28.81 17.49 18.06 14.68 11.66 InsightsROE Outperforming 5 Year Average
Company delivered ROE of 19.69% in year ending Mar 31, 2024 outperforming its 5 year avg. of 13.06%. (Source: Standalone Financials)
Found Financials useful?
Albert David Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Albert David Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 57.72% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 57.72% return as compared to Nifty Pharma which gave investors 56.71% return over 3 year time period. (as of last trading session)
Mutual Funds Ownership
No Data Available
Albert David Top Searches
Corporate Actions
Board Meeting
Quarterly Results
Feb 03, 2025
General Meeting
-
Nov 26, 2024
Board Meeting
Quarterly Results
Nov 06, 2024
Announced on Meeting on Feb 03, 2025 Feb 12, 2025 Quarterly Results Nov 06, 2024 Nov 14, 2024 Quarterly Results Aug 02, 2024 Aug 09, 2024 Quarterly Results May 06, 2024 May 13, 2024 Audited Results & Final Dividend Jan 25, 2024 Feb 05, 2024 Quarterly Results Announced on Ex-Date Dividend% May 13, 2024 Aug 02, 2024 115% May 19, 2023 Aug 03, 2023 90% May 11, 2022 Aug 01, 2022 90% Jun 17, 2021 Sep 06, 2021 60% Mar 03, 2020 Mar 13, 2020 70% No Data Available
No Data Available
Announced on Ex-Date Mar 12, 1996 Feb 05, 1996 Rights ratio: 2 share for every 3 held at a price of Rs 20.0 Sep 30, 1993 Mar 26, 1993 Rights ratio: 1 share for every 2 held at a price of Rs 20.0 Announced on Meeting on Nov 26, 2024 Dec 28, 2024 - May 13, 2024 Aug 09, 2024 Book closure from Aug 3, 2024 to Aug 9, 2024 Nov 15, 2023 Dec 18, 2023 - Jul 18, 2023 Aug 10, 2023 A.G.M. Jul 05, 2022 Aug 09, 2022 Book closure from Aug 3, 2022 to Aug 9, 2022
About Albert David
Albert David Ltd., incorporated in the year 1938, is a Small Cap company (having a market cap of Rs 470.27 Crore) operating in Pharmaceuticals sector.
Industry
Key Indices Listed On
-
Address
D - Block, 3rd Floor,Gillander House,Netaji Subhas Road,Kolkata, West Bengal - 700001
Executive Leadership
Arun Kumar Kothari
Executive ChairmanUmesh Manohar Kunte
Managing Director & CEOAnand Vardhan Kothari
Non Executive DirectorPrabhawati Devi Kothari
Non Executive DirectorAuditors
FAQs about Albert David share
- 1. What's Albert David share price today and what are Albert David share returns ?As of today Albert David share price is up by 1.33% basis the previous closing price of Rs 851.3. Albert David share price is Rs 834.90.
- 2. What is 52 week high/low of Albert David share price?In last 52 weeks Albert David share had a high price of Rs 1,753.95 and low price of Rs 810.10
- 3. How can I quickly analyze Albert David stock?Albert David share can be quickly analyzed on following metrics:
- Stock's PE is 11.78
- Price to Book Ratio of 1.23
- 4. What's the market capitalization of Albert David?Albert David share has a market capitalization of Rs 476.29 Cr. Within Pharmaceuticals sector, it's market cap rank is 85.
- 5. What is the CAGR of Albert David?The CAGR of Albert David is 10.01.
- 6. Who is the Chief Executive Officer of Albert David?Umesh Manohar Kunte is the Managing Director & CEO of Albert David
- 7. What is the PE & PB ratio of Albert David?The PE ratio of Albert David stands at 11.63, while the PB ratio is 1.23.
- 8. Who's the chairman of Albert David?Arun Kumar Kothari is the Executive Chairman of Albert David
- 9. What are the Albert David quarterly results?On Standalone basis, Albert David reported a total income and loss of Rs 74.08 Cr and Rs -9.39 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 420.01 Cr and Rs 75.42 Cr.
- 10. Is Albert David giving dividend?Albert David Ltd. announced an equity dividend of 115% on a face value of 10.0 amounting to Rs 11.5 per share on 13 May 2024. The ex dividend date was 02 Aug 2024.
- 11. Who's the owner of Albert David?
- Promoter holding has not changed in last 9 months and holds 62.13 stake as on 31 Dec 2024
- Domestic Institutional Investors holding have gone down from 1.66 (31 Mar 2024) to 1.62 (31 Dec 2024)
- Foreign Institutional Investors holding have gone down from 0.98 (31 Mar 2024) to 0.86 (31 Dec 2024)
- Other investor holding has gone up from 35.23 (31 Mar 2024) to 35.39 (31 Dec 2024)
- 12. Which are the key peers to Albert David?Within Pharmaceuticals sector Albert David, Medicamen Biotech Ltd., Medico Remedies Ltd., Ind-Swift Laboratories Ltd., Wanbury Ltd., Nectar Lifesciences Ltd., Zim Laboratories Ltd., Kilitch Drugs(I) Ltd., Lyka Labs Ltd., Kopran Ltd. and Venus Remedies Ltd. are usually compared together by investors for analysis.
Top Gainers
As on 11:32 AM | 04 Mar 2025Top Losers
As on 11:34 AM | 04 Mar 2025Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.